Syros Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
SYRS on OTC
Industry
Pharmaceutical Preparations
Location
35 Cambridge Park Drive, Cambridge, MA

Insiders trading volume in the past year

Syros Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Timothy Tyson Director $164K Jun 5, 2024
Marsha Fanucci Director $79.2K Jun 5, 2024
Wirth Peter Director $79.2K Jun 5, 2024
Deborah Dunsire Director $79.2K Jun 5, 2024
Andrew M. Oh Director $79.2K Jun 5, 2024
Sue Gail Eckhardt Director $79.2K Jun 5, 2024
Eric R. Olson Chief Scientific Officer $42.8K Jul 17, 2023
Gerald E. Quirk Chief Legal & Compliance Offic $33.5K Nov 19, 2024
Mark J. Alles Director $28K Sep 16, 2023
Richard A. Young Director $22.4K Sep 16, 2024
Srinivas Akkaraju Director $20.1K Sep 16, 2024
Nancy A. Simonian Director $1.08K -$45.8K -97.7% Dec 2, 2024
David Roth Chief Medical Officer $0 Nov 18, 2024
Kristin Stephens Chief Development Officer $0 Nov 18, 2024
Conley Chee President & CEO, Director $0 Nov 18, 2024
Jason Haas Chief Financial Officer $0 Nov 18, 2024
Amir Nashat Director Jun 1, 2022
Sharp Phillip A Director Jun 1, 2022

Recent Insider Transactions by Companies or Individuals for Syros Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.